Literature DB >> 832230

Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance.

R L Ridolfi, P P Rosen, H Thaler.   

Abstract

Aggregates of cells resembling those of cutaneous nevi have been found in the capsules of lymph nodes. Although seemingly rare, this extraordinary lesion could conceivably occur often enough to be more than a pathological curiosity, and should be differentiated from metastatic tumor. Slides from every axillary lymph node dissection for female mammary carcinoma in the years 1964 and 1974 at Memorial Hospital were reviewed, as were slides from 100 consecutive lymph node dissections performed during 1974 in patients with malignant melanoma. Nevus cell aggregates (NCA) were associated with three of 17,504 lymph nodes (0.017%) obtained from 909 mastectomies, or 0.33% of the cases. Among the 100 lymph node dissections for malignant melanoma, NCA were found associated with three of the 2,607 lymph nodes examined (0.12%), or 3.0% of the cases studied. Since NCA occur in association with lymph nodes more often than previously thought, the possibility that they may be a potential source of malignant melanoma in patients without a demonstrable cutaneous or mucosal primary is discussed.

Entities:  

Mesh:

Year:  1977        PMID: 832230     DOI: 10.1002/1097-0142(197701)39:1<164::aid-cncr2820390127>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience.

Authors:  Giuseppe Viale; Mauro G Mastropasqua; Eugenio Maiorano; Giovanni Mazzarol
Journal:  Virchows Arch       Date:  2005-11-24       Impact factor: 4.064

2.  Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas.

Authors:  A G Nicholson; C G Marks; M G Cook
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Case Report of a Large Pigmented Epithelioid Melanocytoma With Suspected Lymph Node Metastases.

Authors:  Rie Akita; Yoshihiro Sowa; Daiki Morita; Toshiaki Numajiri
Journal:  Eplasty       Date:  2016-12-16

4.  Benign lymph node inclusions mimicking metastatic carcinoma.

Authors:  C J Fisher; S Hill; R R Millis
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.

Authors:  Jad Saab; Maria Laureana Santos-Zabala; Massimo Loda; Edward C Stack; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2018-04       Impact factor: 1.533

6.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

7.  Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients.

Authors:  N Hatta; M Takata; K Takehara; K Ohara
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

8.  Improved survival for stage IV melanoma from an unknown primary site.

Authors:  Chris C Lee; Mark B Faries; Leslie A Wanek; Donald L Morton
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

9.  Immunostaining for the tumour suppressor gene p16 product is a useful marker to differentiate melanoma metastasis from lymph-node nevus.

Authors:  Daniela Mihic-Probst; Parvin Saremaslani; Paul Komminoth; Philipp U Heitz
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

10.  The ultrastructure of congenital nevocytic nevi. I. Nevus cells in walls of blood vessels and lymphatics.

Authors:  B V Schneider; O Maie
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.